Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals has informed the BSE that its trading window for dealing in company securities will be closed from January 1, 2026 until 48 hours after the announcement of its unaudited financial results for the quarter ended December 31, 2025. The closure applies to promoters, promoter group members, directors, key managerial personnel, insiders, designated persons, connected persons, and their immediate relatives. This is a routine compliance measure under SEBI's Insider Trading Regulations, 2015. The date of the board meeting to approve the Q3 results has not yet been disclosed and will be announced separately.
No direct impact on shareholders — this is a standard regulatory compliance filing. However, it signals that the Q3 FY26 results announcement is approaching, which could bring near-term price movement depending on the numbers reported.